| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | adenylate cyclase activator activity | 7.43e-08 | 5 | 40 | 3 | GO:0010856 | |
| GeneOntologyMolecularFunction | type 3 metabotropic glutamate receptor binding | 1.48e-07 | 6 | 40 | 3 | GO:0031800 | |
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 6.20e-07 | 9 | 40 | 3 | GO:0010854 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 8.85e-07 | 10 | 40 | 3 | GO:0030235 | |
| GeneOntologyMolecularFunction | cyclase activator activity | 2.10e-06 | 13 | 40 | 3 | GO:0010853 | |
| GeneOntologyMolecularFunction | titin binding | 2.67e-06 | 14 | 40 | 3 | GO:0031432 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor binding | 4.10e-06 | 16 | 40 | 3 | GO:0035256 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 4.10e-06 | 16 | 40 | 3 | GO:0008179 | |
| GeneOntologyMolecularFunction | protein phosphatase activator activity | 4.97e-06 | 17 | 40 | 3 | GO:0072542 | |
| GeneOntologyMolecularFunction | cyclase regulator activity | 5.95e-06 | 18 | 40 | 3 | GO:0010851 | |
| GeneOntologyMolecularFunction | phosphatase activator activity | 8.29e-06 | 20 | 40 | 3 | GO:0019211 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 1.12e-05 | 22 | 40 | 3 | GO:0050998 | |
| GeneOntologyMolecularFunction | calcium-dependent protein binding | 4.35e-05 | 98 | 40 | 4 | GO:0048306 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 8.69e-05 | 43 | 40 | 3 | GO:0043548 | |
| GeneOntologyMolecularFunction | calcium channel regulator activity | 1.72e-04 | 54 | 40 | 3 | GO:0005246 | |
| GeneOntologyMolecularFunction | helicase activity | 2.76e-04 | 158 | 40 | 4 | GO:0004386 | |
| GeneOntologyMolecularFunction | calcium channel inhibitor activity | 3.01e-04 | 13 | 40 | 2 | GO:0019855 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 3.81e-04 | 172 | 40 | 4 | GO:0044325 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 5.11e-04 | 78 | 40 | 3 | GO:0043539 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 5.70e-04 | 81 | 40 | 3 | GO:0035254 | |
| GeneOntologyMolecularFunction | protein phosphatase regulator activity | 1.05e-03 | 100 | 40 | 3 | GO:0019888 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.30e-03 | 614 | 40 | 6 | GO:0140657 | |
| GeneOntologyMolecularFunction | phosphatase regulator activity | 1.50e-03 | 113 | 40 | 3 | GO:0019208 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.79e-03 | 441 | 40 | 5 | GO:0016887 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.83e-03 | 262 | 40 | 4 | GO:0140097 | |
| GeneOntologyMolecularFunction | histone binding | 1.90e-03 | 265 | 40 | 4 | GO:0042393 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.09e-03 | 127 | 40 | 3 | GO:0008094 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 2.25e-03 | 465 | 40 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.49e-03 | 37 | 40 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | protein kinase activator activity | 3.29e-03 | 149 | 40 | 3 | GO:0030295 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.41e-03 | 151 | 40 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | kinase activator activity | 3.94e-03 | 159 | 40 | 3 | GO:0019209 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 4.16e-03 | 162 | 40 | 3 | GO:0099106 | |
| GeneOntologyMolecularFunction | ion channel inhibitor activity | 4.16e-03 | 48 | 40 | 2 | GO:0008200 | |
| GeneOntologyMolecularFunction | channel inhibitor activity | 4.51e-03 | 50 | 40 | 2 | GO:0016248 | |
| GeneOntologyMolecularFunction | transporter inhibitor activity | 4.69e-03 | 51 | 40 | 2 | GO:0141110 | |
| GeneOntologyMolecularFunction | channel regulator activity | 5.07e-03 | 174 | 40 | 3 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 5.32e-03 | 177 | 40 | 3 | GO:0141108 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 7.97e-03 | 627 | 40 | 5 | GO:0022890 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 8.95e-03 | 645 | 40 | 5 | GO:0140640 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.01e-02 | 664 | 40 | 5 | GO:0008324 | |
| GeneOntologyBiologicalProcess | calcium ion export across plasma membrane | 5.34e-09 | 12 | 39 | 4 | GO:1990034 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclic-nucleotide phosphodiesterase activity | 6.25e-09 | 3 | 39 | 3 | GO:0051343 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion export across plasma membrane | 6.23e-08 | 5 | 39 | 3 | GO:1905913 | |
| GeneOntologyBiologicalProcess | negative regulation of voltage-gated calcium channel activity | 6.38e-08 | 21 | 39 | 4 | GO:1901386 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion export across plasma membrane | 1.25e-07 | 6 | 39 | 3 | GO:1905912 | |
| GeneOntologyBiologicalProcess | regulation of cyclic-nucleotide phosphodiesterase activity | 1.25e-07 | 6 | 39 | 3 | GO:0051342 | |
| GeneOntologyBiologicalProcess | negative regulation of high voltage-gated calcium channel activity | 3.48e-07 | 8 | 39 | 3 | GO:1901842 | |
| GeneOntologyBiologicalProcess | positive regulation of ryanodine-sensitive calcium-release channel activity | 5.21e-07 | 9 | 39 | 3 | GO:0060316 | |
| GeneOntologyBiologicalProcess | regulation of voltage-gated calcium channel activity | 7.69e-07 | 38 | 39 | 4 | GO:1901385 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transporter activity | 8.08e-07 | 92 | 39 | 5 | GO:1901019 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transporter activity | 8.56e-07 | 39 | 39 | 4 | GO:1901021 | |
| GeneOntologyBiologicalProcess | negative regulation of ryanodine-sensitive calcium-release channel activity | 1.02e-06 | 11 | 39 | 3 | GO:0060315 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transmembrane transporter activity | 1.05e-06 | 41 | 39 | 4 | GO:1901020 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling involved in cardiac conduction | 1.36e-06 | 12 | 39 | 3 | GO:1901844 | |
| GeneOntologyBiologicalProcess | detection of calcium ion | 1.76e-06 | 13 | 39 | 3 | GO:0005513 | |
| GeneOntologyBiologicalProcess | regulation of high voltage-gated calcium channel activity | 3.44e-06 | 16 | 39 | 3 | GO:1901841 | |
| GeneOntologyBiologicalProcess | negative regulation of cation channel activity | 3.73e-06 | 56 | 39 | 4 | GO:2001258 | |
| GeneOntologyBiologicalProcess | positive regulation of cation channel activity | 3.73e-06 | 56 | 39 | 4 | GO:2001259 | |
| GeneOntologyBiologicalProcess | negative regulation of release of sequestered calcium ion into cytosol | 4.17e-06 | 17 | 39 | 3 | GO:0051280 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 4.35e-06 | 359 | 39 | 7 | GO:0006874 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling | 5.00e-06 | 18 | 39 | 3 | GO:0010649 | |
| GeneOntologyBiologicalProcess | positive regulation of sequestering of calcium ion | 5.93e-06 | 19 | 39 | 3 | GO:0051284 | |
| GeneOntologyBiologicalProcess | regulation of cation channel activity | 5.98e-06 | 138 | 39 | 5 | GO:2001257 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 7.35e-06 | 389 | 39 | 7 | GO:0055074 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transmembrane transport | 8.63e-06 | 69 | 39 | 4 | GO:1903170 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 9.39e-06 | 22 | 39 | 3 | GO:0010881 | |
| GeneOntologyBiologicalProcess | negative regulation of peptidyl-threonine phosphorylation | 1.23e-05 | 24 | 39 | 3 | GO:0010801 | |
| GeneOntologyBiologicalProcess | regulation of ryanodine-sensitive calcium-release channel activity | 1.58e-05 | 26 | 39 | 3 | GO:0060314 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling involved in cardiac conduction | 1.58e-05 | 26 | 39 | 3 | GO:0086064 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | 1.76e-05 | 622 | 39 | 8 | GO:0098771 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane transport | 1.89e-05 | 175 | 39 | 5 | GO:0034763 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by calcium ion signaling | 1.98e-05 | 28 | 39 | 3 | GO:0010882 | |
| GeneOntologyBiologicalProcess | negative regulation of ion transmembrane transporter activity | 2.17e-05 | 87 | 39 | 4 | GO:0032413 | |
| GeneOntologyBiologicalProcess | positive regulation of protein autophosphorylation | 2.21e-05 | 29 | 39 | 3 | GO:0031954 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | 2.37e-05 | 854 | 39 | 9 | GO:1903047 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell action potential | 2.45e-05 | 30 | 39 | 3 | GO:0098901 | |
| GeneOntologyBiologicalProcess | export across plasma membrane | 2.59e-05 | 91 | 39 | 4 | GO:0140115 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transport | 2.71e-05 | 92 | 39 | 4 | GO:0051926 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatase activity | 2.71e-05 | 31 | 39 | 3 | GO:0010922 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-threonine phosphorylation | 2.98e-05 | 32 | 39 | 3 | GO:0010800 | |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 3.28e-05 | 33 | 39 | 3 | GO:0010880 | |
| GeneOntologyBiologicalProcess | positive regulation of ion transmembrane transporter activity | 3.33e-05 | 97 | 39 | 4 | GO:0032414 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 3.76e-05 | 100 | 39 | 4 | GO:0061337 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling | 3.92e-05 | 35 | 39 | 3 | GO:0010644 | |
| GeneOntologyBiologicalProcess | cytokinesis | 3.95e-05 | 204 | 39 | 5 | GO:0000910 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | 4.31e-05 | 705 | 39 | 8 | GO:0055080 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 4.64e-05 | 37 | 39 | 3 | GO:0014808 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | 4.85e-05 | 717 | 39 | 8 | GO:0050801 | |
| GeneOntologyBiologicalProcess | positive regulation of transporter activity | 4.90e-05 | 107 | 39 | 4 | GO:0032411 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport | 5.26e-05 | 109 | 39 | 4 | GO:1904427 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transport | 5.41e-05 | 218 | 39 | 5 | GO:1903169 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 5.45e-05 | 39 | 39 | 3 | GO:1903514 | |
| GeneOntologyBiologicalProcess | negative regulation of transporter activity | 5.45e-05 | 110 | 39 | 4 | GO:0032410 | |
| GeneOntologyBiologicalProcess | negative regulation of cation transmembrane transport | 6.71e-05 | 116 | 39 | 4 | GO:1904063 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 7.84e-05 | 44 | 39 | 3 | GO:0070296 | |
| GeneOntologyBiologicalProcess | substantia nigra development | 8.39e-05 | 45 | 39 | 3 | GO:0021762 | |
| GeneOntologyBiologicalProcess | negative regulation of monoatomic ion transmembrane transport | 8.70e-05 | 124 | 39 | 4 | GO:0034766 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 8.70e-05 | 392 | 39 | 6 | GO:0070588 | |
| GeneOntologyBiologicalProcess | regulation of protein autophosphorylation | 8.97e-05 | 46 | 39 | 3 | GO:0031952 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | 9.03e-05 | 1014 | 39 | 9 | GO:0000278 | |
| GeneOntologyBiologicalProcess | autophagosome membrane docking | 9.68e-05 | 8 | 39 | 2 | GO:0016240 | |
| GeneOntologyBiologicalProcess | positive regulation of release of sequestered calcium ion into cytosol | 1.02e-04 | 48 | 39 | 3 | GO:0051281 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transporter activity | 1.16e-04 | 256 | 39 | 5 | GO:0032412 | |
| GeneOntologyBiologicalProcess | mitochondrion-endoplasmic reticulum membrane tethering | 1.24e-04 | 9 | 39 | 2 | GO:1990456 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-threonine phosphorylation | 1.30e-04 | 52 | 39 | 3 | GO:0010799 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | 1.30e-04 | 611 | 39 | 7 | GO:0030003 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane transporter activity | 1.38e-04 | 266 | 39 | 5 | GO:0022898 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | 1.46e-04 | 622 | 39 | 7 | GO:0006873 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | 1.53e-04 | 845 | 39 | 8 | GO:0010564 | |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 1.89e-04 | 59 | 39 | 3 | GO:0086065 | |
| GeneOntologyBiologicalProcess | G2/M transition of mitotic cell cycle | 1.91e-04 | 152 | 39 | 4 | GO:0000086 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 2.01e-04 | 154 | 39 | 4 | GO:0051928 | |
| GeneOntologyBiologicalProcess | positive regulation of dephosphorylation | 2.19e-04 | 62 | 39 | 3 | GO:0035306 | |
| GeneOntologyBiologicalProcess | regulation of transporter activity | 2.38e-04 | 299 | 39 | 5 | GO:0032409 | |
| GeneOntologyBiologicalProcess | cell cycle process | SMARCA2 MCM2 SAC3D1 NCAPD3 CUL7 CALM1 MBD4 CHMP4B CALM2 CALM3 | 2.62e-04 | 1441 | 39 | 10 | GO:0022402 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 2.77e-04 | 922 | 39 | 8 | GO:0098662 | |
| GeneOntologyBiologicalProcess | cell division | 2.92e-04 | 697 | 39 | 7 | GO:0051301 | |
| GeneOntologyBiologicalProcess | cell cycle G2/M phase transition | 2.99e-04 | 171 | 39 | 4 | GO:0044839 | |
| GeneOntologyBiologicalProcess | negative regulation of monoatomic ion transport | 2.99e-04 | 171 | 39 | 4 | GO:0043271 | |
| GeneOntologyBiologicalProcess | autophagosome maturation | 3.00e-04 | 69 | 39 | 3 | GO:0097352 | |
| GeneOntologyBiologicalProcess | positive regulation of cation transmembrane transport | 3.20e-04 | 174 | 39 | 4 | GO:1904064 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 3.20e-04 | 942 | 39 | 8 | GO:0098655 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | 3.40e-04 | 323 | 39 | 5 | GO:0051924 | |
| GeneOntologyBiologicalProcess | neural nucleus development | 3.41e-04 | 72 | 39 | 3 | GO:0048857 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 3.58e-04 | 509 | 39 | 6 | GO:0006816 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle phase transition | 3.58e-04 | 509 | 39 | 6 | GO:0044772 | |
| GeneOntologyBiologicalProcess | regulation of phosphatase activity | 3.69e-04 | 74 | 39 | 3 | GO:0010921 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transmembrane transport | 4.64e-04 | 192 | 39 | 4 | GO:0034767 | |
| GeneOntologyBiologicalProcess | metal ion transport | 4.77e-04 | 1000 | 39 | 8 | GO:0030001 | |
| GeneOntologyBiologicalProcess | regulation of action potential | 4.82e-04 | 81 | 39 | 3 | GO:0098900 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 5.34e-04 | 1017 | 39 | 8 | GO:0098660 | |
| GeneOntologyBiologicalProcess | organelle localization by membrane tethering | 5.55e-04 | 85 | 39 | 3 | GO:0140056 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 5.94e-04 | 87 | 39 | 3 | GO:0086001 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction | 6.34e-04 | 89 | 39 | 3 | GO:0055117 | |
| GeneOntologyBiologicalProcess | membrane docking | 6.77e-04 | 91 | 39 | 3 | GO:0022406 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic cation transmembrane transport | 7.11e-04 | 380 | 39 | 5 | GO:1904062 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 7.34e-04 | 217 | 39 | 4 | GO:0097553 | |
| GeneOntologyBiologicalProcess | negative regulation of transport | 7.60e-04 | 587 | 39 | 6 | GO:0051051 | |
| GeneOntologyBiologicalProcess | import into cell | 7.65e-04 | 1074 | 39 | 8 | GO:0098657 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane transport | 7.73e-04 | 589 | 39 | 6 | GO:0034762 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.14e-05 | 73 | 40 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | synaptic vesicle | 2.12e-05 | 300 | 40 | 6 | GO:0008021 | |
| GeneOntologyCellularComponent | spindle microtubule | 2.18e-05 | 86 | 40 | 4 | GO:0005876 | |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 2.72e-05 | 91 | 40 | 4 | GO:0008076 | |
| GeneOntologyCellularComponent | exocytic vesicle | 3.04e-05 | 320 | 40 | 6 | GO:0070382 | |
| GeneOntologyCellularComponent | calyx of Held | 4.44e-05 | 36 | 40 | 3 | GO:0044305 | |
| GeneOntologyCellularComponent | potassium channel complex | 4.60e-05 | 104 | 40 | 4 | GO:0034705 | |
| GeneOntologyCellularComponent | motile cilium | 5.42e-05 | 355 | 40 | 6 | GO:0031514 | |
| GeneOntologyCellularComponent | cation channel complex | 8.21e-05 | 235 | 40 | 5 | GO:0034703 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 8.72e-05 | 238 | 40 | 5 | GO:0097729 | |
| GeneOntologyCellularComponent | sarcomere | 1.08e-04 | 249 | 40 | 5 | GO:0030017 | |
| GeneOntologyCellularComponent | myofibril | 1.66e-04 | 273 | 40 | 5 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 2.19e-04 | 290 | 40 | 5 | GO:0043292 | |
| GeneOntologyCellularComponent | presynapse | 2.32e-04 | 886 | 40 | 8 | GO:0098793 | |
| GeneOntologyCellularComponent | sperm midpiece | 2.49e-04 | 64 | 40 | 3 | GO:0097225 | |
| GeneOntologyCellularComponent | spindle | 2.54e-04 | 471 | 40 | 6 | GO:0005819 | |
| GeneOntologyCellularComponent | cilium | 2.54e-04 | 898 | 40 | 8 | GO:0005929 | |
| GeneOntologyCellularComponent | supramolecular fiber | 3.13e-04 | 1179 | 40 | 9 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 3.29e-04 | 1187 | 40 | 9 | GO:0099081 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 3.73e-04 | 179 | 40 | 4 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 3.73e-04 | 179 | 40 | 4 | GO:0030672 | |
| GeneOntologyCellularComponent | transport vesicle | 4.26e-04 | 519 | 40 | 6 | GO:0030133 | |
| GeneOntologyCellularComponent | centrosome | 5.77e-04 | 770 | 40 | 7 | GO:0005813 | |
| GeneOntologyCellularComponent | sperm flagellum | 7.31e-04 | 214 | 40 | 4 | GO:0036126 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 7.36e-04 | 378 | 40 | 5 | GO:0034702 | |
| GeneOntologyCellularComponent | myelin sheath | 7.70e-04 | 217 | 40 | 4 | GO:0043209 | |
| GeneOntologyCellularComponent | growth cone | 1.21e-03 | 245 | 40 | 4 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 1.36e-03 | 253 | 40 | 4 | GO:0030427 | |
| GeneOntologyCellularComponent | microtubule organizing center | 1.62e-03 | 919 | 40 | 7 | GO:0005815 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 2.32e-03 | 293 | 40 | 4 | GO:0030658 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 3.07e-03 | 523 | 40 | 5 | GO:1902495 | |
| GeneOntologyCellularComponent | microtubule | 3.33e-03 | 533 | 40 | 5 | GO:0005874 | |
| GeneOntologyCellularComponent | transporter complex | 3.81e-03 | 550 | 40 | 5 | GO:1990351 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 4.32e-03 | 817 | 40 | 6 | GO:0098978 | |
| GeneOntologyCellularComponent | chromatin | 6.20e-03 | 1480 | 40 | 8 | GO:0000785 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 6.84e-03 | 899 | 40 | 6 | GO:0099513 | |
| GeneOntologyCellularComponent | spindle pole | 7.03e-03 | 205 | 40 | 3 | GO:0000922 | |
| GeneOntologyCellularComponent | axon terminus | 7.51e-03 | 210 | 40 | 3 | GO:0043679 | |
| GeneOntologyCellularComponent | chromosomal region | 8.36e-03 | 421 | 40 | 4 | GO:0098687 | |
| GeneOntologyCellularComponent | secretory vesicle | 8.68e-03 | 1246 | 40 | 7 | GO:0099503 | |
| GeneOntologyCellularComponent | distal axon | 9.36e-03 | 435 | 40 | 4 | GO:0150034 | |
| GeneOntologyCellularComponent | neuron projection terminus | 9.97e-03 | 233 | 40 | 3 | GO:0044306 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | 1.11e-02 | 1307 | 40 | 7 | GO:0030659 | |
| GeneOntologyCellularComponent | vesicle membrane | 1.20e-02 | 1325 | 40 | 7 | GO:0012506 | |
| HumanPheno | Polymorphic ventricular tachycardia | 8.23e-06 | 10 | 22 | 3 | HP:0031677 | |
| HumanPheno | 2:1 atrioventricular block | 1.78e-05 | 2 | 22 | 2 | HP:0034305 | |
| HumanPheno | Second degree atrioventricular block | 3.08e-05 | 15 | 22 | 3 | HP:0011706 | |
| HumanPheno | T-wave alternans | 5.33e-05 | 3 | 22 | 2 | HP:0012266 | |
| HumanPheno | Abnormal cardiac exercise stress test | 6.48e-05 | 19 | 22 | 3 | HP:0500018 | |
| HumanPheno | Torsade de pointes | 1.51e-04 | 25 | 22 | 3 | HP:0001664 | |
| MousePheno | abnormal aerobic fitness | 1.59e-05 | 20 | 35 | 3 | MP:0000348 | |
| MousePheno | decreased heart rate | 7.12e-05 | 288 | 35 | 6 | MP:0005333 | |
| MousePheno | increased aerobic running capacity | 9.08e-05 | 6 | 35 | 2 | MP:0003060 | |
| MousePheno | abnormal heart rate | 9.81e-05 | 445 | 35 | 7 | MP:0001629 | |
| MousePheno | abnormal heartbeat | 2.05e-04 | 501 | 35 | 7 | MP:0004085 | |
| Domain | Helicase_C | 1.33e-03 | 107 | 38 | 3 | PF00271 | |
| Domain | HELICc | 1.33e-03 | 107 | 38 | 3 | SM00490 | |
| Domain | Helicase_C | 1.37e-03 | 108 | 38 | 3 | IPR001650 | |
| Domain | HELICASE_CTER | 1.41e-03 | 109 | 38 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.41e-03 | 109 | 38 | 3 | PS51192 | |
| Domain | DEXDc | 1.41e-03 | 109 | 38 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.44e-03 | 110 | 38 | 3 | IPR014001 | |
| Domain | SNF2_N | 1.92e-03 | 32 | 38 | 2 | PF00176 | |
| Domain | SNF2_N | 1.92e-03 | 32 | 38 | 2 | IPR000330 | |
| Domain | EF-hand-dom_pair | 2.67e-03 | 287 | 38 | 4 | IPR011992 | |
| Domain | WD40_repeat_dom | 3.02e-03 | 297 | 38 | 4 | IPR017986 | |
| Domain | - | 3.69e-03 | 746 | 38 | 6 | 3.40.50.300 | |
| Domain | WD40/YVTN_repeat-like_dom | 4.64e-03 | 335 | 38 | 4 | IPR015943 | |
| Domain | P-loop_NTPase | 6.85e-03 | 848 | 38 | 6 | IPR027417 | |
| Domain | EF_HAND_1 | 8.18e-03 | 204 | 38 | 3 | PS00018 | |
| Domain | EF_HAND_2 | 1.15e-02 | 231 | 38 | 3 | PS50222 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 2.45e-08 | 14 | 33 | 4 | MM15391 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 2.45e-08 | 14 | 33 | 4 | MM15052 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 7.44e-08 | 18 | 33 | 4 | MM15577 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.17e-07 | 5 | 33 | 3 | MM14493 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.14e-07 | 23 | 33 | 4 | M47512 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS | 2.33e-07 | 6 | 33 | 3 | MM15662 | |
| Pathway | REACTOME_CAM_PDE_1_ACTIVATION | 2.33e-07 | 6 | 33 | 3 | MM14494 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 4.06e-07 | 7 | 33 | 3 | MM1357 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 4.20e-07 | 27 | 33 | 4 | MM15053 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 9.72e-07 | 9 | 33 | 3 | M3412 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 1.10e-06 | 34 | 33 | 4 | MM15985 | |
| Pathway | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | 1.39e-06 | 10 | 33 | 3 | MM14570 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE | 1.39e-06 | 10 | 33 | 3 | M47954 | |
| Pathway | REACTOME_CALCINEURIN_ACTIVATES_NFAT | 1.90e-06 | 11 | 33 | 3 | MM14810 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.90e-06 | 11 | 33 | 3 | M47958 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 2.14e-06 | 40 | 33 | 4 | M39595 | |
| Pathway | REACTOME_ENOS_ACTIVATION | 2.53e-06 | 12 | 33 | 3 | MM14817 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 2.53e-06 | 12 | 33 | 3 | MM15142 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY | 2.53e-06 | 12 | 33 | 3 | M47956 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 3.29e-06 | 13 | 33 | 3 | MM15078 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 4.18e-06 | 14 | 33 | 3 | MM1473 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 4.18e-06 | 14 | 33 | 3 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 4.18e-06 | 14 | 33 | 3 | M47388 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 5.22e-06 | 15 | 33 | 3 | M47385 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 5.22e-06 | 15 | 33 | 3 | M15181 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 5.22e-06 | 15 | 33 | 3 | MM15103 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 5.22e-06 | 15 | 33 | 3 | MM1387 | |
| Pathway | REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION | 5.22e-06 | 15 | 33 | 3 | MM14795 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 6.41e-06 | 16 | 33 | 3 | MM1483 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 6.41e-06 | 16 | 33 | 3 | M47449 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 6.41e-06 | 16 | 33 | 3 | MM14492 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 7.25e-06 | 54 | 33 | 4 | MM15202 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 7.77e-06 | 17 | 33 | 3 | M2349 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 7.77e-06 | 17 | 33 | 3 | M10066 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 7.77e-06 | 17 | 33 | 3 | M47387 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN | 7.77e-06 | 17 | 33 | 3 | M47560 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 7.77e-06 | 17 | 33 | 3 | M5940 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 7.77e-06 | 17 | 33 | 3 | MM1372 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 9.01e-06 | 57 | 33 | 4 | MM15643 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 9.31e-06 | 18 | 33 | 3 | M3430 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 9.31e-06 | 18 | 33 | 3 | M47580 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 9.31e-06 | 18 | 33 | 3 | M5290 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 9.31e-06 | 18 | 33 | 3 | MM1385 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 1.10e-05 | 19 | 33 | 3 | MM1453 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 1.10e-05 | 19 | 33 | 3 | M47543 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 1.10e-05 | 19 | 33 | 3 | M47957 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 1.30e-05 | 20 | 33 | 3 | MM1445 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 1.51e-05 | 21 | 33 | 3 | M47542 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 1.51e-05 | 21 | 33 | 3 | M11650 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.75e-05 | 22 | 33 | 3 | MM15104 | |
| Pathway | REACTOME_PROTEIN_METHYLATION | 1.75e-05 | 22 | 33 | 3 | MM15519 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 2.00e-05 | 23 | 33 | 3 | MM15222 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.29e-05 | 24 | 33 | 3 | M47509 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.46e-05 | 151 | 33 | 5 | M39329 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 2.60e-05 | 25 | 33 | 3 | MM1441 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.60e-05 | 25 | 33 | 3 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.60e-05 | 25 | 33 | 3 | M47511 | |
| Pathway | REACTOME_METABOLISM_OF_COFACTORS | 2.60e-05 | 25 | 33 | 3 | MM15574 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 2.60e-05 | 25 | 33 | 3 | M1547 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 2.83e-05 | 76 | 33 | 4 | MM15051 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 2.83e-05 | 76 | 33 | 4 | M9052 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 2.93e-05 | 26 | 33 | 3 | MM1346 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 2.93e-05 | 26 | 33 | 3 | M17941 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 2.93e-05 | 26 | 33 | 3 | MM1431 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 2.93e-05 | 26 | 33 | 3 | MM14495 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 2.93e-05 | 26 | 33 | 3 | MM1371 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 3.29e-05 | 27 | 33 | 3 | M14899 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 3.29e-05 | 27 | 33 | 3 | M7739 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 3.68e-05 | 28 | 33 | 3 | MM14711 | |
| Pathway | BIOCARTA_NO1_PATHWAY | 3.68e-05 | 28 | 33 | 3 | M4383 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 3.68e-05 | 28 | 33 | 3 | M47508 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 4.10e-05 | 29 | 33 | 3 | MM1356 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 4.10e-05 | 29 | 33 | 3 | M13494 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 4.10e-05 | 29 | 33 | 3 | MM15219 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 4.10e-05 | 29 | 33 | 3 | MM1495 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 4.55e-05 | 30 | 33 | 3 | MM15170 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 4.55e-05 | 30 | 33 | 3 | M9664 | |
| Pathway | REACTOME_THE_PHOTOTRANSDUCTION_CASCADE | 5.02e-05 | 31 | 33 | 3 | MM14896 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 5.41e-05 | 178 | 33 | 5 | M2890 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 5.53e-05 | 32 | 33 | 3 | MM1355 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 5.53e-05 | 32 | 33 | 3 | MM15143 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 6.08e-05 | 33 | 33 | 3 | M9494 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 6.66e-05 | 34 | 33 | 3 | M10287 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 6.66e-05 | 34 | 33 | 3 | MM1399 | |
| Pathway | REACTOME_RAF_ACTIVATION | 7.27e-05 | 35 | 33 | 3 | MM15271 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 7.27e-05 | 35 | 33 | 3 | MM15109 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 7.27e-05 | 35 | 33 | 3 | MM15114 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 8.66e-05 | 101 | 33 | 4 | M1979 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 9.34e-05 | 103 | 33 | 4 | MM15196 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 1.01e-04 | 39 | 33 | 3 | M1908 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.01e-04 | 39 | 33 | 3 | MM14496 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 1.01e-04 | 39 | 33 | 3 | MM1397 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 1.26e-04 | 42 | 33 | 3 | MM1504 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 1.43e-04 | 115 | 33 | 4 | M9387 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 1.45e-04 | 44 | 33 | 3 | M39845 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 1.45e-04 | 44 | 33 | 3 | M19784 | |
| Pathway | REACTOME_CA2_PATHWAY | 1.55e-04 | 45 | 33 | 3 | MM15040 | |
| Pathway | REACTOME_RAS_PROCESSING | 1.55e-04 | 45 | 33 | 3 | MM15671 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 1.88e-04 | 48 | 33 | 3 | MM14589 | |
| Pathway | BIOCARTA_NFAT_PATHWAY | 2.00e-04 | 49 | 33 | 3 | MM1442 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 29932249 | ||
| Pubmed | Calmodulin is required for cell-cycle progression during G1 and mitosis. | 1.41e-09 | 3 | 40 | 3 | 2469574 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 18370588 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 21799007 | ||
| Pubmed | Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo. | 1.41e-09 | 3 | 40 | 3 | 15632291 | |
| Pubmed | Structural organization of the human CaMIII calmodulin gene. | 1.41e-09 | 3 | 40 | 3 | 2223880 | |
| Pubmed | Molecular mechanisms of calmodulin's functional versatility. | 1.41e-09 | 3 | 40 | 3 | 9923700 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 9681195 | ||
| Pubmed | Calmodulin is a functional regulator of Cav1.4 L-type Ca2+ channels. | 1.41e-09 | 3 | 40 | 3 | 19717559 | |
| Pubmed | Allosteric mechanism of water-channel gating by Ca2+-calmodulin. | 1.41e-09 | 3 | 40 | 3 | 23893133 | |
| Pubmed | Binding of calmodulin to the HIV-1 matrix protein triggers myristate exposure. | 1.41e-09 | 3 | 40 | 3 | 20956522 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 18940602 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 25268113 | ||
| Pubmed | Expression of HIV-1 envelope glycoprotein alters cellular calmodulin. | 1.41e-09 | 3 | 40 | 3 | 8573130 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 19651602 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 10899953 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 26969752 | ||
| Pubmed | Noncanonical binding of calmodulin to aquaporin-0: implications for channel regulation. | 1.41e-09 | 3 | 40 | 3 | 18786401 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 8314583 | ||
| Pubmed | Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. | 1.41e-09 | 3 | 40 | 3 | 11807546 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 11072229 | ||
| Pubmed | Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin. | 1.41e-09 | 3 | 40 | 3 | 9278050 | |
| Pubmed | Blocking the Ca2+-induced conformational transitions in calmodulin with disulfide bonds. | 1.41e-09 | 3 | 40 | 3 | 8631777 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 15719022 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 8312049 | ||
| Pubmed | Nef of HIV-1 interacts directly with calcium-bound calmodulin. | 1.41e-09 | 3 | 40 | 3 | 11847276 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 18553937 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 10416864 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 16229872 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 7828884 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 14978283 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 8862395 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 37380439 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 15063758 | ||
| Pubmed | Calmodulin and HIV type 1: interactions with Gag and Gag products. | 1.41e-09 | 3 | 40 | 3 | 11054265 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 33191766 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 31628181 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 8226798 | ||
| Pubmed | Sequence homology of the 3'-untranslated region of calmodulin III in mammals. | 1.41e-09 | 3 | 40 | 3 | 11710561 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 2445749 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 9658102 | ||
| Pubmed | The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity. | 1.41e-09 | 3 | 40 | 3 | 17582331 | |
| Pubmed | Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulin. | 1.41e-09 | 3 | 40 | 3 | 9362478 | |
| Pubmed | The abundance of calmodulin mRNAs is regulated in phosphorylase kinase-deficient skeletal muscle. | 1.41e-09 | 3 | 40 | 3 | 3384819 | |
| Pubmed | Calmodulin binding to the Fas death domain. Regulation by Fas activation. | 5.63e-09 | 4 | 40 | 3 | 14594800 | |
| Pubmed | Structure of calmodulin bound to the hydrophobic IQ domain of the cardiac Ca(v)1.2 calcium channel. | 5.63e-09 | 4 | 40 | 3 | 16338416 | |
| Pubmed | Role of calmodulin in HIV-potentiated Fas-mediated apoptosis. | 5.63e-09 | 4 | 40 | 3 | 8780394 | |
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 19279214 | ||
| Pubmed | Endogenous calmodulin interacts with the epidermal growth factor receptor in living cells. | 5.63e-09 | 4 | 40 | 3 | 14960328 | |
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 25437912 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 22405011 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 17046994 | ||
| Pubmed | A calmodulin-binding sequence in the C-terminus of human cardiac titin kinase. | 5.63e-09 | 4 | 40 | 3 | 7607248 | |
| Pubmed | A network of control mediated by regulator of calcium/calmodulin-dependent signaling. | 5.63e-09 | 4 | 40 | 3 | 15499021 | |
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 10692436 | ||
| Pubmed | Requirement of calmodulin binding by HIV-1 gp160 for enhanced FAS-mediated apoptosis. | 5.63e-09 | 4 | 40 | 3 | 10625668 | |
| Pubmed | Molecular basis of the death-associated protein kinase-calcium/calmodulin regulator complex. | 5.63e-09 | 4 | 40 | 3 | 20103772 | |
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 27516456 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 11736632 | ||
| Pubmed | Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures. | 5.63e-09 | 4 | 40 | 3 | 29724949 | |
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 16478480 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 21167176 | ||
| Pubmed | Calcium/calmodulin regulates ubiquitination of the ubiquitin-specific protease TRE17/USP6. | 5.63e-09 | 4 | 40 | 3 | 16127172 | |
| Pubmed | A calcium sensor in the sodium channel modulates cardiac excitability. | 5.63e-09 | 4 | 40 | 3 | 11807557 | |
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 11286509 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 9096366 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 12577052 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 20953164 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 20226167 | ||
| Pubmed | FRET detection of calmodulin binding to the cardiac RyR2 calcium release channel. | 5.63e-09 | 4 | 40 | 3 | 22067155 | |
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 30842726 | ||
| Pubmed | Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. | 5.63e-09 | 4 | 40 | 3 | 23040497 | |
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 25441029 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 10823944 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 19855925 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 16299511 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 16505387 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 26164367 | ||
| Pubmed | Calm1 signaling pathway is essential for the migration of mouse precerebellar neurons. | 5.63e-09 | 4 | 40 | 3 | 25519244 | |
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 18570893 | ||
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 27165696 | ||
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 15140941 | ||
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 9242710 | ||
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 11981030 | ||
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 12034722 | ||
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 25232683 | ||
| Pubmed | Rab3B in human platelet is membrane bound and interacts with Ca(2+)/calmodulin. | 1.41e-08 | 5 | 40 | 3 | 11741295 | |
| Pubmed | Current inhibition of human EAG1 potassium channels by the Ca2+ binding protein S100B. | 1.41e-08 | 5 | 40 | 3 | 20708613 | |
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 32522888 | ||
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 22705208 | ||
| Pubmed | Pathogenic NPHP5 mutations impair protein interaction with Cep290, a prerequisite for ciliogenesis. | 1.41e-08 | 5 | 40 | 3 | 23446637 | |
| Pubmed | Inhibition of human ether à go-go potassium channels by Ca(2+)/calmodulin. | 1.41e-08 | 5 | 40 | 3 | 10880439 | |
| Pubmed | Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors. | 1.41e-08 | 5 | 40 | 3 | 19632986 | |
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 3111527 | ||
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 21436055 | ||
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 17719545 | ||
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 25703379 | ||
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 35568036 | ||
| Pubmed | Non-equivalence of embryonic and somatic cell nuclei affecting spindle composition in clones. | 2.81e-08 | 6 | 40 | 3 | 16310175 | |
| Pubmed | 2.81e-08 | 6 | 40 | 3 | 12051765 | ||
| Interaction | PPEF1 interactions | 5.06e-08 | 52 | 39 | 5 | int:PPEF1 | |
| Interaction | CALM2 interactions | 1.23e-07 | 206 | 39 | 7 | int:CALM2 | |
| Interaction | CALM1 interactions | 2.19e-07 | 626 | 39 | 10 | int:CALM1 | |
| Interaction | SPATA17 interactions | 2.33e-07 | 7 | 39 | 3 | int:SPATA17 | |
| Interaction | KCNN1 interactions | 3.73e-07 | 8 | 39 | 3 | int:KCNN1 | |
| Interaction | ARPP21 interactions | 3.73e-07 | 8 | 39 | 3 | int:ARPP21 | |
| Interaction | MYL6 interactions | 5.21e-07 | 255 | 39 | 7 | int:MYL6 | |
| Interaction | NSMF interactions | 6.00e-07 | 35 | 39 | 4 | int:NSMF | |
| Interaction | IQCG interactions | 7.97e-07 | 10 | 39 | 3 | int:IQCG | |
| Interaction | CABP4 interactions | 1.46e-06 | 12 | 39 | 3 | int:CABP4 | |
| Interaction | IQSEC2 interactions | 1.54e-06 | 44 | 39 | 4 | int:IQSEC2 | |
| Interaction | C11orf65 interactions | 1.89e-06 | 13 | 39 | 3 | int:C11orf65 | |
| Interaction | UNC13B interactions | 3.03e-06 | 52 | 39 | 4 | int:UNC13B | |
| Interaction | RPS8 interactions | 3.14e-06 | 649 | 39 | 9 | int:RPS8 | |
| Interaction | ZNF280A interactions | 3.69e-06 | 16 | 39 | 3 | int:ZNF280A | |
| Interaction | CAMTA2 interactions | 5.36e-06 | 18 | 39 | 3 | int:CAMTA2 | |
| Interaction | IQGAP3 interactions | 7.42e-06 | 141 | 39 | 5 | int:IQGAP3 | |
| Interaction | TBC1D1 interactions | 7.45e-06 | 65 | 39 | 4 | int:TBC1D1 | |
| Interaction | RPS10 interactions | 1.06e-05 | 567 | 39 | 8 | int:RPS10 | |
| Interaction | SUPT16H interactions | 1.95e-05 | 442 | 39 | 7 | int:SUPT16H | |
| Interaction | GTPBP4 interactions | 1.98e-05 | 443 | 39 | 7 | int:GTPBP4 | |
| Interaction | KIF1B interactions | 2.00e-05 | 173 | 39 | 5 | int:KIF1B | |
| Interaction | KCNQ2 interactions | 2.07e-05 | 84 | 39 | 4 | int:KCNQ2 | |
| Interaction | H4C4 interactions | 2.36e-05 | 29 | 39 | 3 | int:H4C4 | |
| Interaction | PPEF2 interactions | 2.36e-05 | 29 | 39 | 3 | int:PPEF2 | |
| Interaction | ESCO1 interactions | 2.62e-05 | 30 | 39 | 3 | int:ESCO1 | |
| Interaction | MKI67 interactions | 2.79e-05 | 648 | 39 | 8 | int:MKI67 | |
| Interaction | PHKG2 interactions | 2.84e-05 | 91 | 39 | 4 | int:PHKG2 | |
| Interaction | PDE4DIP interactions | 3.06e-05 | 189 | 39 | 5 | int:PDE4DIP | |
| Interaction | SH2B1 interactions | 3.20e-05 | 32 | 39 | 3 | int:SH2B1 | |
| Interaction | POC5 interactions | 3.36e-05 | 95 | 39 | 4 | int:POC5 | |
| Interaction | H3C13 interactions | 3.51e-05 | 33 | 39 | 3 | int:H3C13 | |
| Interaction | PPP3CB interactions | 3.79e-05 | 98 | 39 | 4 | int:PPP3CB | |
| Interaction | H4C5 interactions | 3.85e-05 | 34 | 39 | 3 | int:H4C5 | |
| Interaction | MAPT interactions | SMARCA2 TNIK PIP4K2B PYGM SNAP25 CALM1 CHMP4B WDR7 CALM3 ATP2B3 | 3.88e-05 | 1119 | 39 | 10 | int:MAPT |
| Interaction | OBSL1 interactions | 4.37e-05 | 902 | 39 | 9 | int:OBSL1 | |
| Interaction | KIF1A interactions | 4.44e-05 | 102 | 39 | 4 | int:KIF1A | |
| Interaction | SRRT interactions | 4.50e-05 | 340 | 39 | 6 | int:SRRT | |
| Interaction | TOP1 interactions | 4.63e-05 | 696 | 39 | 8 | int:TOP1 | |
| Interaction | RPL13 interactions | 4.82e-05 | 700 | 39 | 8 | int:RPL13 | |
| Interaction | IQCE interactions | 4.97e-05 | 37 | 39 | 3 | int:IQCE | |
| Interaction | MACROH2A2 interactions | 5.17e-05 | 211 | 39 | 5 | int:MACROH2A2 | |
| Interaction | MYL6B interactions | 5.55e-05 | 108 | 39 | 4 | int:MYL6B | |
| Interaction | PRKAR2A interactions | 5.91e-05 | 217 | 39 | 5 | int:PRKAR2A | |
| Interaction | CASK interactions | 6.44e-05 | 221 | 39 | 5 | int:CASK | |
| Interaction | AKAP9 interactions | 6.44e-05 | 221 | 39 | 5 | int:AKAP9 | |
| Interaction | MYO9B interactions | 6.62e-05 | 113 | 39 | 4 | int:MYO9B | |
| Interaction | H4C8 interactions | 6.79e-05 | 41 | 39 | 3 | int:H4C8 | |
| Interaction | ERCC6 interactions | 6.86e-05 | 224 | 39 | 5 | int:ERCC6 | |
| Interaction | RPL23 interactions | 6.97e-05 | 540 | 39 | 7 | int:RPL23 | |
| Interaction | H4C15 interactions | 7.30e-05 | 42 | 39 | 3 | int:H4C15 | |
| Interaction | PHKA1 interactions | 7.84e-05 | 43 | 39 | 3 | int:PHKA1 | |
| Interaction | GRM5 interactions | 7.84e-05 | 43 | 39 | 3 | int:GRM5 | |
| Interaction | ITPRID2 interactions | 8.37e-05 | 120 | 39 | 4 | int:ITPRID2 | |
| Interaction | H4C11 interactions | 8.99e-05 | 45 | 39 | 3 | int:H4C11 | |
| Interaction | SFPQ interactions | 9.05e-05 | 563 | 39 | 7 | int:SFPQ | |
| Interaction | CDC73 interactions | 9.08e-05 | 386 | 39 | 6 | int:CDC73 | |
| Interaction | ATP6V1E1 interactions | 9.21e-05 | 123 | 39 | 4 | int:ATP6V1E1 | |
| Interaction | CACNA1A interactions | 9.21e-05 | 123 | 39 | 4 | int:CACNA1A | |
| Interaction | CAMK2G interactions | 9.51e-05 | 240 | 39 | 5 | int:CAMK2G | |
| Interaction | NOP56 interactions | 9.77e-05 | 570 | 39 | 7 | int:NOP56 | |
| Interaction | SF3B1 interactions | 9.88e-05 | 571 | 39 | 7 | int:SF3B1 | |
| Interaction | UBE3B interactions | 1.02e-04 | 47 | 39 | 3 | int:UBE3B | |
| Interaction | H2BC8 interactions | 1.04e-04 | 576 | 39 | 7 | int:H2BC8 | |
| Interaction | CAMKK1 interactions | 1.09e-04 | 48 | 39 | 3 | int:CAMKK1 | |
| Interaction | BIN1 interactions | 1.11e-04 | 129 | 39 | 4 | int:BIN1 | |
| Interaction | KIF23 interactions | 1.22e-04 | 1031 | 39 | 9 | int:KIF23 | |
| Interaction | IQGAP1 interactions | 1.22e-04 | 591 | 39 | 7 | int:IQGAP1 | |
| Interaction | SMC3 interactions | 1.23e-04 | 408 | 39 | 6 | int:SMC3 | |
| Interaction | H4C3 interactions | 1.23e-04 | 50 | 39 | 3 | int:H4C3 | |
| Interaction | FECH interactions | 1.25e-04 | 133 | 39 | 4 | int:FECH | |
| Interaction | RALA interactions | 1.36e-04 | 136 | 39 | 4 | int:RALA | |
| Interaction | RPL26 interactions | 1.42e-04 | 419 | 39 | 6 | int:RPL26 | |
| Interaction | RPL23A interactions | 1.43e-04 | 606 | 39 | 7 | int:RPL23A | |
| Interaction | HNRNPF interactions | 1.44e-04 | 607 | 39 | 7 | int:HNRNPF | |
| Interaction | MIF interactions | 1.49e-04 | 264 | 39 | 5 | int:MIF | |
| Interaction | LMNB1 interactions | 1.49e-04 | 610 | 39 | 7 | int:LMNB1 | |
| Interaction | H4C2 interactions | 1.55e-04 | 54 | 39 | 3 | int:H4C2 | |
| Interaction | H4C12 interactions | 1.55e-04 | 54 | 39 | 3 | int:H4C12 | |
| Interaction | PLEC interactions | 1.64e-04 | 430 | 39 | 6 | int:PLEC | |
| Interaction | ANKS6 interactions | 1.73e-04 | 56 | 39 | 3 | int:ANKS6 | |
| Interaction | MYO1B interactions | 1.74e-04 | 273 | 39 | 5 | int:MYO1B | |
| Interaction | AZGP1 interactions | 1.79e-04 | 146 | 39 | 4 | int:AZGP1 | |
| Interaction | H4C13 interactions | 1.92e-04 | 58 | 39 | 3 | int:H4C13 | |
| Interaction | FBL interactions | 1.98e-04 | 639 | 39 | 7 | int:FBL | |
| Interaction | SMARCE1 interactions | 2.19e-04 | 287 | 39 | 5 | int:SMARCE1 | |
| Interaction | DDX3X interactions | 2.22e-04 | 651 | 39 | 7 | int:DDX3X | |
| Interaction | AGTPBP1 interactions | 2.23e-04 | 61 | 39 | 3 | int:AGTPBP1 | |
| Interaction | RPS6 interactions | 2.25e-04 | 874 | 39 | 8 | int:RPS6 | |
| Interaction | CCDC8 interactions | 2.33e-04 | 656 | 39 | 7 | int:CCDC8 | |
| Interaction | H1-4 interactions | 2.33e-04 | 656 | 39 | 7 | int:H1-4 | |
| Interaction | GSC2 interactions | 2.34e-04 | 62 | 39 | 3 | int:GSC2 | |
| Interaction | TIGD1 interactions | 2.38e-04 | 12 | 39 | 2 | int:TIGD1 | |
| Interaction | SRRM2 interactions | 2.41e-04 | 462 | 39 | 6 | int:SRRM2 | |
| Interaction | PHKB interactions | 2.46e-04 | 63 | 39 | 3 | int:PHKB | |
| Interaction | EP300 interactions | 2.52e-04 | 1401 | 39 | 10 | int:EP300 | |
| Interaction | RPS7 interactions | 2.53e-04 | 466 | 39 | 6 | int:RPS7 | |
| Interaction | PPP2R1A interactions | 2.53e-04 | 665 | 39 | 7 | int:PPP2R1A | |
| Interaction | GLUL interactions | 2.53e-04 | 160 | 39 | 4 | int:GLUL | |
| Interaction | SNX33 interactions | 2.57e-04 | 64 | 39 | 3 | int:SNX33 | |
| GeneFamily | Endogenous ligands | 3.43e-04 | 237 | 26 | 4 | 542 | |
| GeneFamily | EF-hand domain containing | 3.71e-03 | 219 | 26 | 3 | 863 | |
| GeneFamily | WD repeat domain containing | 6.11e-03 | 262 | 26 | 3 | 362 | |
| Coexpression | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP | 2.21e-06 | 17 | 40 | 3 | MM686 | |
| Coexpression | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP | 5.71e-06 | 23 | 40 | 3 | MM694 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 6.76e-06 | 80 | 40 | 4 | MM1285 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MATURE_NEURONS | 9.17e-06 | 186 | 40 | 5 | M39291 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_UNSPECIFIED | 2.47e-05 | 37 | 40 | 3 | M39292 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 4.78e-05 | 46 | 40 | 3 | MM670 | |
| Coexpression | MCCLUNG_DELTA_FOSB_TARGETS_8WK | 6.52e-05 | 51 | 40 | 3 | MM647 | |
| Coexpression | LEIN_NEURON_MARKERS | 1.61e-04 | 69 | 40 | 3 | M1712 | |
| Coexpression | LEIN_NEURON_MARKERS | 1.68e-04 | 70 | 40 | 3 | MM714 | |
| Coexpression | CYCLIN_D1_UP.V1_DN | 1.99e-04 | 190 | 40 | 4 | M2652 | |
| Coexpression | CYCLIN_D1_KE_.V1_DN | 2.03e-04 | 191 | 40 | 4 | M2647 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP | 2.04e-04 | 14 | 40 | 2 | M1353 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP | 2.04e-04 | 14 | 40 | 2 | MM565 | |
| Coexpression | GSE360_L_DONOVANI_VS_T_GONDII_DC_DN | 2.29e-04 | 197 | 40 | 4 | M5196 | |
| Coexpression | GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_UP | 2.38e-04 | 199 | 40 | 4 | M9480 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_DN | 2.38e-04 | 199 | 40 | 4 | M5249 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN | 2.38e-04 | 199 | 40 | 4 | M5251 | |
| Coexpression | GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_UP | 2.42e-04 | 200 | 40 | 4 | M8322 | |
| Coexpression | GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN | 2.42e-04 | 200 | 40 | 4 | M3416 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 2.42e-04 | 200 | 40 | 4 | M9188 | |
| Coexpression | GUO_HEX_TARGETS_UP | 2.49e-04 | 80 | 40 | 3 | MM626 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_31 | 2.87e-04 | 209 | 40 | 4 | MM17088 | |
| Coexpression | PAL_PRMT5_TARGETS_UP | 2.92e-04 | 210 | 40 | 4 | MM1172 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN | 2.98e-04 | 85 | 40 | 3 | MM684 | |
| Coexpression | THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN | 3.92e-04 | 227 | 40 | 4 | M11234 | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.03e-07 | 193 | 40 | 5 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | CV-Mild-3|Mild / Virus stimulation, Condition and Cluster | 1.47e-05 | 166 | 40 | 4 | 5599f90fc0e15a3670b03187085eba91228390a2 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-05 | 176 | 40 | 4 | 87de432c680b80555342afac864599bbc002c040 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.21e-05 | 184 | 40 | 4 | 25ccf08a8a26d7e7827b6357f33a53aaf423577d | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-05 | 190 | 40 | 4 | 4288189e3a499c395896c950598810b02f401685 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-CFuPNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.60e-05 | 192 | 40 | 4 | a8841ebd879f1c344ab4246fdef77044170f644d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 193 | 40 | 4 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 193 | 40 | 4 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 193 | 40 | 4 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.71e-05 | 194 | 40 | 4 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.05e-05 | 200 | 40 | 4 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuronal-Cortical_neuron|1m / Sample Type, Dataset, Time_group, and Cell type. | 3.05e-05 | 200 | 40 | 4 | 0185b4ad6b512d24efff806460ee1b57e42096e9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Mesoderm|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.62e-04 | 139 | 40 | 3 | d441c29852c28928ecb696b4b95e31b30c17116b | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 140 | 40 | 3 | e442c46979d725ec82f525a001c46d971fcade4d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.79e-04 | 142 | 40 | 3 | ae495c8dd733f0fde66bddc281606543f21c0d4b | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated-diff|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.79e-04 | 142 | 40 | 3 | 1e57c75e9f28aae2ca99543448433fa7326398ad | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.15e-04 | 148 | 40 | 3 | 3f48f5ba0a0928ddf6da7a1be1976933921f42ad | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.21e-04 | 149 | 40 | 3 | 65778f19599b4955c0a16f0121237656449431fb | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.34e-04 | 151 | 40 | 3 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.34e-04 | 151 | 40 | 3 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-leukocyte-proliferating_myeloid_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.47e-04 | 153 | 40 | 3 | 596bb7cfd1c713708ce73df30d890a0233eae7f7 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-leukocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.47e-04 | 153 | 40 | 3 | 8cc2667213bfac37545bb63181e88ef1f1834413 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.54e-04 | 154 | 40 | 3 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.54e-04 | 154 | 40 | 3 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.54e-04 | 154 | 40 | 3 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.54e-04 | 154 | 40 | 3 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.61e-04 | 155 | 40 | 3 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.61e-04 | 155 | 40 | 3 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 156 | 40 | 3 | ba9dfee9373d657d2a55572b41fc62001ad8b037 | |
| ToppCell | Control-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.82e-04 | 158 | 40 | 3 | 35aee1c3b92169e73569331022833cb44ab7e7e8 | |
| ToppCell | control-Epithelial-Ciliated-diff|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.03e-04 | 161 | 40 | 3 | ef4b946914a4e2727ed57362dc6965c299520f35 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.25e-04 | 164 | 40 | 3 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.41e-04 | 166 | 40 | 3 | ceb0a48c0d853448fd45ac31dde046df9a178571 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.41e-04 | 166 | 40 | 3 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.41e-04 | 166 | 40 | 3 | f4698fd08965936d51695d571bd10fb77330d916 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.56e-04 | 168 | 40 | 3 | fa7c0303918cea04e3f4c4f3cb079be19004d214 | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Spindle_Cell-1|TCGA-Uvea / Sample_Type by Project: Shred V9 | 4.56e-04 | 168 | 40 | 3 | b427746929bb40e3d1b5f1c40d302b792d6b32a5 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.56e-04 | 168 | 40 | 3 | 7edcab103c69e928d5c19a0d218ffb3ae32f9e70 | |
| ToppCell | control-Epithelial-Ciliated-diff|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.72e-04 | 170 | 40 | 3 | 334c4103eb6e021766f5638a4ab14b59ad085ac7 | |
| ToppCell | droplet-Heart-4Chambers-18m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-04 | 171 | 40 | 3 | 4935a95d11ac997d183fab32cbaad837bf0a512b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.81e-04 | 171 | 40 | 3 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Deuterosomal|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.89e-04 | 172 | 40 | 3 | 08ad76412c9cc3504141797b44b88478ced87476 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.89e-04 | 172 | 40 | 3 | e9b97f37bb1732ad9aa89c5e9b513d14022801ac | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 4.97e-04 | 173 | 40 | 3 | 8a9dd85f718564c07cf3120ad648daeb60c94fc5 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.06e-04 | 174 | 40 | 3 | 00cf27bc23af1472a507be31fba6245a8fdd901b | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_ciliated|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.06e-04 | 174 | 40 | 3 | b8d1c556290d188f56aeefc17f03119686945fe7 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.14e-04 | 175 | 40 | 3 | c82ec6deb6ccdd991a69a62b6d62d5b14c803d7a | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_ciliated|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.14e-04 | 175 | 40 | 3 | b1369d2b74f461e6822d0c33e9b50fe0dfbceb54 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.40e-04 | 178 | 40 | 3 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.40e-04 | 178 | 40 | 3 | c7e890cd02206c516cf1d7692ea7abc8ce746482 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.49e-04 | 179 | 40 | 3 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.67e-04 | 181 | 40 | 3 | 5a4574f1bfd0b4ca78da7effda43420857e17296 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.67e-04 | 181 | 40 | 3 | a4e891603645f694687e68e585744ddc1a3c8697 | |
| ToppCell | P03-Epithelial-airway_epithelial_cell-club_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.67e-04 | 181 | 40 | 3 | 60a91587c59029a34e7bec1255083337fe21b72a | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Ciliated|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.67e-04 | 181 | 40 | 3 | 8eed9d46d924b16f6dd1a025ff612244b02b4391 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.67e-04 | 181 | 40 | 3 | 89c551de26de047c316c91ac1d97bdf728a33d9e | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.67e-04 | 181 | 40 | 3 | e4dbc09f0210de465d8347969b301c22463a2b7d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.67e-04 | 181 | 40 | 3 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | P03-Epithelial-airway_epithelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.67e-04 | 181 | 40 | 3 | 1ea21d860d4d7abab3e21e130a16d044006656ee | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.76e-04 | 182 | 40 | 3 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 5.76e-04 | 182 | 40 | 3 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.76e-04 | 182 | 40 | 3 | b1e66ccd5f33b4801f1cafddf97f5fc0c6dba8d1 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.85e-04 | 183 | 40 | 3 | 3cbe0175d05fd39bc430de1ef471ff2c5b56460e | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-CD5+_CCL22+_mature_B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.95e-04 | 184 | 40 | 3 | 5bb775253a10a14360b06a46aba46d162a9bd1f8 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-04 | 184 | 40 | 3 | 69348c9237e44f7752ac01f60e733ad41580fdb8 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.95e-04 | 184 | 40 | 3 | 797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.95e-04 | 184 | 40 | 3 | a0831e850bc0b585296ed350fdd075c1f730308e | |
| ToppCell | P07-Epithelial-airway_epithelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.95e-04 | 184 | 40 | 3 | a5e7af3392e9d6ddad0397f1eeb6b91ed1107cc2 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-club_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.95e-04 | 184 | 40 | 3 | ab469b9e06212462cbe2e4db8775c6778db855e6 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.95e-04 | 184 | 40 | 3 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.95e-04 | 184 | 40 | 3 | 77d5b60a20b277f589b18f7a131142a7ef2dac17 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.04e-04 | 185 | 40 | 3 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 6.04e-04 | 185 | 40 | 3 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.04e-04 | 185 | 40 | 3 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 6.04e-04 | 185 | 40 | 3 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-club_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.14e-04 | 186 | 40 | 3 | a26811481668fa25c48a064a56c198685693ad8d | |
| ToppCell | P28-Epithelial-airway_epithelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.14e-04 | 186 | 40 | 3 | df80f101954b8ec6ccdb03e702de22e70b65181f | |
| ToppCell | Dividing_Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.14e-04 | 186 | 40 | 3 | 0067eb78d4c7e32b9563550d9fcaf13445ee6a48 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.14e-04 | 186 | 40 | 3 | bca5215d406f1785bf3a420201d5686071fcaca5 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.23e-04 | 187 | 40 | 3 | 1399c703505211c510b3f14c7a2aa9930566c473 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.23e-04 | 187 | 40 | 3 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 6.23e-04 | 187 | 40 | 3 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.23e-04 | 187 | 40 | 3 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.23e-04 | 187 | 40 | 3 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 6.23e-04 | 187 | 40 | 3 | bc1f33f332ac939c2425f510173430ca2ba0c3ee | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.23e-04 | 187 | 40 | 3 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-club_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.23e-04 | 187 | 40 | 3 | a70aaae32426e9ddb1cbfbd0e0db24ccc96b9f40 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.33e-04 | 188 | 40 | 3 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-04 | 188 | 40 | 3 | f1a9d8ea174a4bef0fae8188e3bd96b7ac1a39bb | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 6.33e-04 | 188 | 40 | 3 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.33e-04 | 188 | 40 | 3 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.33e-04 | 188 | 40 | 3 | e3e71c0f2e374330620cb4d27638953ffa9f5298 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.43e-04 | 189 | 40 | 3 | 057d7a03fdbe779122b203619a6f947f49b84d28 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.43e-04 | 189 | 40 | 3 | b55de812043b670cbde810d7d42f45909b6d66ef | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-04 | 189 | 40 | 3 | 3ade3fa9369e85304b20d7233b581f18ad5ecc89 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.43e-04 | 189 | 40 | 3 | 38cde34295566a4ecaf7d0a81c5a192cf17d0459 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.43e-04 | 189 | 40 | 3 | 02c6128a9ab5818e0881dcadafdad5f08b9a67cf | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.43e-04 | 189 | 40 | 3 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.43e-04 | 189 | 40 | 3 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.43e-04 | 189 | 40 | 3 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| Drug | tiflucarbine | 4.00e-09 | 12 | 40 | 4 | CID000065677 | |
| Drug | NSC366363 | 5.02e-09 | 3 | 40 | 3 | CID000339501 | |
| Drug | AC1NDS53 | 5.02e-09 | 3 | 40 | 3 | CID004630710 | |
| Drug | tatsiensine | 5.02e-09 | 3 | 40 | 3 | CID000163526 | |
| Drug | delcosine | 5.02e-09 | 3 | 40 | 3 | CID000120726 | |
| Drug | NSC-114340 | 1.46e-08 | 16 | 40 | 4 | CID000004598 | |
| Drug | quin2 | 1.54e-08 | 95 | 40 | 6 | CID000104841 | |
| Drug | indo-1 | 1.97e-08 | 99 | 40 | 6 | CID000105060 | |
| Drug | thiomethylpromazine | 2.01e-08 | 4 | 40 | 3 | CID000070583 | |
| Drug | KS-504e | 2.01e-08 | 4 | 40 | 3 | CID000129559 | |
| Drug | KS-504d | 2.01e-08 | 4 | 40 | 3 | CID000129557 | |
| Drug | Archanagelicine | 2.01e-08 | 4 | 40 | 3 | CID003083773 | |
| Drug | Nsc642900 | 2.01e-08 | 4 | 40 | 3 | CID000498959 | |
| Drug | CTK0F9956 | 2.01e-08 | 4 | 40 | 3 | CID011779542 | |
| Drug | N,N-dimethyladriamycin-14-valerate | 2.01e-08 | 4 | 40 | 3 | CID000127194 | |
| Drug | 85318-25-8 | 2.01e-08 | 4 | 40 | 3 | CID006439702 | |
| Drug | cloxacepride | 2.01e-08 | 4 | 40 | 3 | CID000068859 | |
| Drug | Roylin | 2.01e-08 | 4 | 40 | 3 | CID000099924 | |
| Drug | chloraniformethan | 2.01e-08 | 4 | 40 | 3 | CID000030331 | |
| Drug | KS-502 | 2.01e-08 | 4 | 40 | 3 | CID000129242 | |
| Drug | KS-501 | 2.01e-08 | 4 | 40 | 3 | CID000129240 | |
| Drug | 2'-methoxykobusin | 2.01e-08 | 4 | 40 | 3 | CID000637889 | |
| Drug | Ti 233 | 2.01e-08 | 4 | 40 | 3 | CID000173248 | |
| Drug | diisopropylphosphoramidite | 2.01e-08 | 4 | 40 | 3 | CID000080867 | |
| Drug | PS-990 | 2.01e-08 | 4 | 40 | 3 | CID000157810 | |
| Drug | herbarumin III | 2.01e-08 | 4 | 40 | 3 | CID000643678 | |
| Drug | 8-azido cyclic AMP | 2.45e-08 | 18 | 40 | 4 | CID000115296 | |
| Drug | AC1L19BP | 2.45e-08 | 18 | 40 | 4 | CID000000477 | |
| Drug | 2brh | 4.78e-08 | 21 | 40 | 4 | CID000848641 | |
| Drug | jujubogenin | 5.01e-08 | 5 | 40 | 3 | CID005318721 | |
| Drug | D 890 | 5.01e-08 | 5 | 40 | 3 | CID000134083 | |
| Drug | 4H-1,4-benzothiazin-3-one | 5.01e-08 | 5 | 40 | 3 | CID000021396 | |
| Drug | Y-acid | 5.01e-08 | 5 | 40 | 3 | CID000007022 | |
| Drug | NSC-36360 | 5.01e-08 | 5 | 40 | 3 | CID000133340 | |
| Drug | C16AA | 5.01e-08 | 5 | 40 | 3 | CID000488017 | |
| Drug | auranthine | 5.01e-08 | 5 | 40 | 3 | CID000130919 | |
| Drug | alpha-CAO | 5.01e-08 | 5 | 40 | 3 | CID000196600 | |
| Drug | AC1NS8P3 | 5.01e-08 | 5 | 40 | 3 | CID005356151 | |
| Drug | Ant-ATP | 5.01e-08 | 5 | 40 | 3 | CID000134953 | |
| Drug | Nor2 chlorpromazine | 5.01e-08 | 5 | 40 | 3 | CID000074981 | |
| Drug | Fsh-beta-(1-15) | 5.01e-08 | 5 | 40 | 3 | CID005748474 | |
| Drug | Ac-dvda | 5.01e-08 | 5 | 40 | 3 | CID000146768 | |
| Drug | VUF 4576 | 5.01e-08 | 5 | 40 | 3 | CID000132784 | |
| Drug | AC1L25Y6 | 7.06e-08 | 23 | 40 | 4 | CID000015465 | |
| Drug | lanthanum chloride hydrate | 7.06e-08 | 23 | 40 | 4 | CID000165791 | |
| Drug | 2,5-diketocamphane | 1.00e-07 | 6 | 40 | 3 | CID000020218 | |
| Drug | AC1NSV6X | 1.00e-07 | 6 | 40 | 3 | CID005317173 | |
| Drug | benziodarone | 1.00e-07 | 6 | 40 | 3 | CID000006237 | |
| Drug | AC1LCMSV | 1.00e-07 | 6 | 40 | 3 | CID000633347 | |
| Drug | CI-922 | 1.00e-07 | 6 | 40 | 3 | CID000146938 | |
| Drug | caged PE | 1.00e-07 | 6 | 40 | 3 | CID000192405 | |
| Drug | N-(8-aminooctyl)-5-iodonaphthalene-1-sulfonamide | 1.00e-07 | 6 | 40 | 3 | CID000004307 | |
| Drug | propyl-methylenedioxyindene | 1.00e-07 | 6 | 40 | 3 | CID000145934 | |
| Drug | hydroxamates | 1.01e-07 | 25 | 40 | 4 | CID000033630 | |
| Drug | cyhexatin | 1.01e-07 | 25 | 40 | 4 | CID005364545 | |
| Drug | 1-(4-pyridyl)ethanol | 1.75e-07 | 7 | 40 | 3 | CID000090919 | |
| Drug | MS-857 | 1.75e-07 | 7 | 40 | 3 | CID000129517 | |
| Drug | SQ 65442 | 1.75e-07 | 7 | 40 | 3 | CID000128039 | |
| Drug | AC1L3PE4 | 1.75e-07 | 7 | 40 | 3 | CID000093048 | |
| Drug | AC1L52O2 | 1.75e-07 | 7 | 40 | 3 | CID000196983 | |
| Drug | O-4-(ethoxybutyl)berbamine | 1.75e-07 | 7 | 40 | 3 | CID000188375 | |
| Drug | chloronitromethane | 1.75e-07 | 7 | 40 | 3 | CID000074529 | |
| Drug | trifluoperazine sulfoxide | 1.75e-07 | 7 | 40 | 3 | CID000159622 | |
| Drug | TZC-5665 | 1.75e-07 | 7 | 40 | 3 | CID006449836 | |
| Drug | KHL-8430 | 1.75e-07 | 7 | 40 | 3 | CID000195711 | |
| Drug | CPU57 | 1.75e-07 | 7 | 40 | 3 | CID000195730 | |
| Drug | DyCl3 | 1.75e-07 | 7 | 40 | 3 | CID000066207 | |
| Drug | Drnflrfamide | 1.75e-07 | 7 | 40 | 3 | CID000132879 | |
| Drug | 4-hydroxyphenylglycol | 1.75e-07 | 7 | 40 | 3 | CID003081980 | |
| Drug | DAPpNP | 1.75e-07 | 7 | 40 | 3 | CID005492375 | |
| Drug | T 7188 | 1.75e-07 | 7 | 40 | 3 | CID000003311 | |
| Drug | asocainol | 1.75e-07 | 7 | 40 | 3 | CID000071161 | |
| Drug | nimodipine | 1.93e-07 | 145 | 40 | 6 | CID000004497 | |
| Drug | Bay K 8644 | 2.36e-07 | 150 | 40 | 6 | CID000002303 | |
| Drug | 3,7,8-trihydroxy-CPZ | 2.80e-07 | 8 | 40 | 3 | CID000467415 | |
| Drug | proxyl nitroxide | 2.80e-07 | 8 | 40 | 3 | CID000076702 | |
| Drug | niludipine | 2.80e-07 | 8 | 40 | 3 | CID000089767 | |
| Drug | KS-504a | 2.80e-07 | 8 | 40 | 3 | CID000129577 | |
| Drug | NSP-805 | 2.80e-07 | 8 | 40 | 3 | CID000130349 | |
| Drug | Ro 22-4839 | 2.80e-07 | 8 | 40 | 3 | CID000065839 | |
| Drug | HT-74 | 2.80e-07 | 8 | 40 | 3 | CID000126681 | |
| Drug | 2,6-ANS | 2.80e-07 | 8 | 40 | 3 | CID002762570 | |
| Drug | AC1MJ4D0 | 2.80e-07 | 8 | 40 | 3 | CID003085362 | |
| Drug | deuteroheme | 3.65e-07 | 34 | 40 | 4 | CID000167768 | |
| Drug | w66 | 4.19e-07 | 9 | 40 | 3 | CID006439460 | |
| Drug | 7,8-diOH-CPZ | 4.19e-07 | 9 | 40 | 3 | CID000159916 | |
| Drug | picumast | 4.19e-07 | 9 | 40 | 3 | CID000431850 | |
| Drug | 5-exo-hydroxycamphor | 4.19e-07 | 9 | 40 | 3 | CID000440017 | |
| Drug | adamantanone | 4.19e-07 | 9 | 40 | 3 | CID000064151 | |
| Drug | KS-505a | 4.19e-07 | 9 | 40 | 3 | CID003081782 | |
| Drug | NSC406942 | 4.61e-07 | 565 | 40 | 9 | CID000001115 | |
| Drug | MIANS | 5.17e-07 | 37 | 40 | 4 | CID000119532 | |
| Drug | 1-isoamyl-3-isobutylxanthine | 5.98e-07 | 10 | 40 | 3 | CID000152034 | |
| Drug | norchlorpromazine | 5.98e-07 | 10 | 40 | 3 | CID000062875 | |
| Drug | Kr I | 5.98e-07 | 10 | 40 | 3 | CID005288675 | |
| Drug | AC1L8MM4 | 5.98e-07 | 10 | 40 | 3 | CID000429016 | |
| Drug | Ins(1,3)P2 | 8.21e-07 | 11 | 40 | 3 | CID000128419 | |
| Drug | indolidan | 8.21e-07 | 11 | 40 | 3 | CID005284402 | |
| Drug | 1-(5-aminopentyl)-3-phenylthiourea | 8.21e-07 | 11 | 40 | 3 | CID003035524 | |
| Drug | 4-iodotamoxifen | 8.21e-07 | 11 | 40 | 3 | CID003037006 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 2.16e-07 | 10 | 37 | 3 | C1631597 | |
| Disease | cancer (implicated_via_orthology) | 9.74e-07 | 268 | 37 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | glucagon measurement, glucose tolerance test | 2.29e-05 | 6 | 37 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | Phencyclidine-Related Disorders | 3.20e-05 | 7 | 37 | 2 | C0236742 | |
| Disease | Phencyclidine Abuse | 3.20e-05 | 7 | 37 | 2 | C0031391 | |
| Disease | Cannabis Abuse | 6.84e-05 | 10 | 37 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 6.84e-05 | 10 | 37 | 2 | C0236735 | |
| Disease | Hashish Abuse | 6.84e-05 | 10 | 37 | 2 | C0018614 | |
| Disease | anti-topoisomerase-I-antibody-positive systemic scleroderma | 6.84e-05 | 10 | 37 | 2 | EFO_0008537 | |
| Disease | superior frontal gyrus grey matter volume measurement | 1.38e-04 | 14 | 37 | 2 | EFO_0006516 | |
| Disease | Romano-Ward Syndrome | 1.82e-04 | 16 | 37 | 2 | C0035828 | |
| Disease | Cannabis Dependence | 2.06e-04 | 17 | 37 | 2 | C0006870 | |
| Disease | Autistic Disorder | 3.14e-04 | 261 | 37 | 4 | C0004352 | |
| Disease | pyruvate measurement | 3.47e-04 | 268 | 37 | 4 | EFO_0010117 | |
| Disease | Marijuana Abuse | 6.51e-04 | 30 | 37 | 2 | C0024809 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EVDEMIREADIDGDG | 121 | P0DP25 | |
| GREETDLEEDEELMQ | 176 | Q8N157 | |
| GEEFDEDELMAELEE | 156 | Q9H444 | |
| EVDEMIREADIDGDG | 121 | P0DP24 | |
| DEMTDEELAEGEEEI | 1076 | Q16720 | |
| GEEDEEMIESIENLE | 161 | P49736 | |
| ARREGADMEEEEEEE | 801 | O60840 | |
| LDEELEIDLDDEAME | 2926 | Q15751 | |
| EEGSDIEDEDMEELL | 541 | Q8NHQ9 | |
| QREVEAIMEGDEEDR | 1456 | A6NKB5 | |
| LGFEEDIEDMVEADE | 431 | Q14999 | |
| GEEEEEEEELQRMLP | 141 | Q13568 | |
| SEGEEEELLMEEEEE | 181 | Q8N594 | |
| EELLMEEEEEDVLAG | 186 | Q8N594 | |
| DEIRAVEEEEMELGE | 1926 | Q8TD57 | |
| CMRDVEEEEEEEGLE | 86 | Q5T0F9 | |
| MEVLREKVEEEEEAE | 1 | Q8IY82 | |
| KEDVAMELERVGEDE | 36 | O95243 | |
| EVDEMIREADIDGDG | 121 | P0DP23 | |
| EEHEVLEVIEDGDME | 491 | O94868 | |
| EEAIEEMERDGLERA | 171 | P22830 | |
| VVREEEMGEEEEVER | 1286 | Q14839 | |
| EMGEEEEVEREIIKQ | 1291 | Q14839 | |
| EEEEEEVLALDMDDE | 76 | Q9NQZ2 | |
| GRTLEEVVMAEEEDE | 381 | A6NKF1 | |
| EEIERIMSGQEFEEE | 151 | Q15406 | |
| LRAIEDGNLEEMEEE | 1326 | P51531 | |
| HDVDRAEQEEMEVEE | 286 | P78356 | |
| AEQEEMEVEERAEDE | 291 | P78356 | |
| GQDVEGERMEIVELE | 501 | P17812 | |
| MERGEEEEEEELVTV | 191 | Q8WYR4 | |
| AIEVDREIAEEEESM | 621 | Q99884 | |
| DEQGEQLERIEEGMD | 51 | P60880 | |
| EDIEMDEIIEEQEDE | 186 | P42695 | |
| MDVTGDEEEEIKQEI | 56 | Q9UKE5 | |
| LGLDMEELEEIEEDA | 116 | P11217 | |
| GIEVEESDEFIREDM | 86 | Q9P246 | |
| REEEEEMDDEAIIAA | 1126 | Q5VZP5 | |
| EEEEEEEVLESCMVG | 426 | Q12899 | |
| EEMVEAAGEDERELA | 821 | Q15393 | |
| EEEEEREEDLMPEKR | 171 | P20396 | |
| EEEEEEMLISEEEIP | 211 | Q96JP5 | |
| EHLLDDEEEDEEIMR | 756 | Q9Y4E6 |